Stockreport

FDA grants Breakthrough Therapy Designation for Xolair for food allergies [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Genentech, a member of the Roche Group ( OTCQX:RHHBY ), announces that the FDA has granted Breakthrough Therapy Designation for Xolair  (omalizum [Read more]